Skip to content

Frontlight ResearchEarly access

Trial site

Rejuvaderm /ID# 255850

Edmonton, Alberta T5N 1L5, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Atopic dermatitis (eczema)

Closed trials

Completed
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
NCT05394792· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Rejuvaderm /ID# 255850: trial site – Frontlight Research